| Identification | Back Directory | [Name]
R 82913 | [CAS]
126347-69-1 | [Synonyms]
R 82913 9-Cl-Tibo NSC 637653 TIBO-R82913 TIBO-R-82913 9-Chloro TIBO R82913. 9-Cmbib NSC 637653, 9-Cl-Tibo 4,5,6,7-Tetrahydro-5α-methyl-6-(3-methyl-2-butenyl)-9-chloroimidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione (+)-(S)-4,5,6,7-tetrahydro-9-chloro-5-methyl-6-(3-methyl-2-butenyl)imidazo<4,5,1-jk><1,4>benzodiazepine-2(1H)-thione [5S,(+)]-4,5,6,7-Tetrahydro-9-chloro-5-methyl-6-(3-methyl-2-butenyl)imidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione Imidazo[4,5,1-jk][1,4]benzodiazepine-2(1H)-thione, 9-chloro-4,5,6,7-tetrahydro-5-methyl-6-(3-methyl-2-buten-1-yl)-, (5S)- | [Molecular Formula]
C16H20ClN3S | [MDL Number]
MFCD00132888 | [MOL File]
126347-69-1.mol | [Molecular Weight]
321.87 |
| Hazard Information | Back Directory | [Uses]
R82913 (9-Cl-TIBO) is a potent and high selective inhibitor of HIV-1 reverse transcriptase with antiviral activity on both an RNA template (negative strand synthesis) and a DNA template (positive strand synthesis). R82913 inhibits the replication of different strains of HIV-I in CEM cells with a median IC50 value of of 0.15 μM[1][2]. | [References]
[1] White EL, et al. A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res. 1991 Oct;16(3):257-66. DOI:10.1016/0166-3542(91)90005-c [2] Larder BA. 3'-Azido-3'-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 1992 Dec;36(12):2664-9. DOI:10.1128/AAC.36.12.2664 |
|
|